Inhibition of TRPC6 by low pH of the tumor environment could be an advantageous factor, considering that this channel is also highly expressed in cancer-infiltrating immune cells (see Section 5.1) and in stromal cells such as pancreatic stellate cells [140]. Here, TRPC6 is linked to cancer.